Paolo Del Fiore
Biographic Data
| ID | 9997574 |
|---|---|
| NAME | Paolo Del Fiore |
| GIVEN NAMES | Paolo |
| FAMILY NAME | Del Fiore |
| SIGNATURE | DEL FIORE P |
| AFFILIATIONS | Istituto Oncologico Veneto |
| ORCID | 0000-0002-2862-8014 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Healthcare costs of cutaneous melanoma according to comorbidity patterns
Background: Cutaneous malignant melanoma represents a notable public health issue, characterized by a rapidly increasing incidence, particularly among younger populations. Despite progress in early detection and treatment modalities, this rising trend exacerbates the healthcare system's burden. Limited research has been conducted on the impact of comorbidities on overall and melanoma-specific healthcare costs incurred by patients with melanoma. T…
Synchronous and metachronous multiple primary cancers in melanoma survivors
Background: Long-term survivors of cutaneous malignant melanoma (CMM) risk subsequent malignancies due to both host-related and environmental risk factors. This retrospective population-based study differentially assesses the risk of synchronous and metachronous cancers in a cohort of CMM survivors stratified by sex. Methods: The cohort study (1999-2018) included 9,726 CMM survivors (M = 4,873, F = 4,853) recorded by the cancer registry of all 5,…
Impact of Wide Local Excision on Melanoma Patient Survival
Introduction Promoting standardization and quality assurance (QA) in oncology on the strength of real-world data is essential to ensure better patient outcomes. Wide excision after primary tumor biopsy is a fundamental step in the therapeutic pathway for cutaneous malignant melanoma (CMM). The aim of this population-based cohort study is to assess adherence to wide local excision in a cohort of patients diagnosed with CMM and the impact of this r…
No prominent works on this page.
Impact of Wide Local Excision on Melanoma Patient Survival
Introduction Promoting standardization and quality assurance (QA) in oncology on the strength of real-world data is essential to ensure better patient outcomes. Wide excision after primary tumor biopsy is a fundamental step in the therapeutic pathway for cutaneous malignant melanoma (CMM). The aim of this population-based cohort study is to assess adherence to wide local excision in a cohort of patients diagnosed with CMM and the impact of this r…
Synchronous and metachronous multiple primary cancers in melanoma survivors
Background: Long-term survivors of cutaneous malignant melanoma (CMM) risk subsequent malignancies due to both host-related and environmental risk factors. This retrospective population-based study differentially assesses the risk of synchronous and metachronous cancers in a cohort of CMM survivors stratified by sex. Methods: The cohort study (1999-2018) included 9,726 CMM survivors (M = 4,873, F = 4,853) recorded by the cancer registry of all 5,…
Healthcare costs of cutaneous melanoma according to comorbidity patterns
Background: Cutaneous malignant melanoma represents a notable public health issue, characterized by a rapidly increasing incidence, particularly among younger populations. Despite progress in early detection and treatment modalities, this rising trend exacerbates the healthcare system's burden. Limited research has been conducted on the impact of comorbidities on overall and melanoma-specific healthcare costs incurred by patients with melanoma. T…
Cancer (3 works) · Cancer registry (3 works) · Cutaneous Melanoma Detection and Management (3 works) · Cohort (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Oncology (2 works) · Population (2 works) · Cancer Immunotherapy and Biomarkers (1 work) · Cancer survivorship and care (1 work)